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Formation of the glycoprotein gH/gL heterooligomer has important implications for understanding the pathology of human
herpesvirus-6 (HHV-6)-associated disease because this complex is essential for infectivity and fusogenic cell-to-cell spread.
Definition of the HHV-6 gH domain involved in protein–protein interactions was addressed by targeting regions defined by
conserved cysteines identified by alignment of gH amino acid sequences representative of all herpesvirus subfamilies.
Studies using site-directed mutagenesis and transient cellular expression showed that the N-terminus of HHV-6 gH includes
a 230-amino-acid domain required for interaction with HHV-6 gL encompassing residues conserved specifically amongst
betaherpesviruses. Interestingly, the human cytomegalovirus (HCMV) homologues, UL75 (gH) or UL115 (gL), can substitute
for HHV-6 glycoproteins and participate in heterologous complex formation. Furthermore, the region which governs this
heterologous gL binding also maps to the N-terminal portion of HHV-6 gH. Although both proteins can functionally substitute
for complex formation there are also specific differences. Surprisingly, further deletion of HHV-6 gH to 145-amino-acid-
domain residues abolishes complex formation with HHV-6 gL but allows interaction with HCMV gL. This may be related to
requirements in HHV-6 for homodimer formation before complex formation between gH and gL. Under nonreducing condi-
tions HHV-6 gH and gL form multimeric complexes consistent with intra- and intermolecular dimer formation stabilised by
disulphide bonds whereas for HCMV there is no evidence for dimer formation for gH and multimeric complexes have only
been observed between gH and gL. In summary, both HHV-6 and HCMV glycoproteins can interact and the heterologous
complex between HHV-6 gH and HCMV gL is possibly more stable. This may result in important biological consequences
in vivo during cellular coinfections by facilitating spread of the viruses, with applications to altered cellular tropisms and
effects on reactivation from the latently infected cell. q 1996 Academic Press, Inc.
INTRODUCTION sented (Challoner et al., 1995). Further, in AIDS patients
widely disseminated infections have been observed and
In most instances, primary HHV-6 infection is asymp- there are speculations on its role in AIDS progression
tomatic or causes exanthem subitum (Yamanishi et al., (Lusso et al., 1989; Fairfax et al., 1994; Corbellino et al.,
1988; Dewhurst et al., 1992) and seroconversion typically 1993; Knox and Carrigan, 1994, 1995; Knox et al., 1995b).
occurs early in infancy (Briggs et al., 1988; Okuno et al., Moreover, there is evidence that HHV-6 infection can
1989) The virus has a preferred cellular tropism in vivo result in immunodeficiency from bone marrow suppres-
for CD4/ T-lymphocytes and undergoes lytic replication sion in immunocompetent individuals (Gompels et al.,
in this cell type (Tedder et al., 1987; Takahashi et al., 1994; Knox et al., 1995a).
1989). Also, there is evidence for a lifelong latent or per- A major cytopathic effect in HHV-6 infections is the for-
sistent infection in sites that include salivary gland epi- mation of cytomegalia, ‘‘giant cells,’’ caused by T-lympho-
thelial cells and monocyte/macrophages (Fox et al., 1990; cyte cell membrane fusion (Tedder et al., 1987; Wyatt et
Kondo et al., 1991). In immunocompromised situations, al., 1990). This appears as the predominant route of spread
HHV-6 can reactivate and is associated with secondary from cell to cell during HHV-6 infection. Monoclonal anti-
infections with life threatening complications in trans- bodies (MAbs) raised against HHV-6 which can inhibit this
plant recipients or cancer patients such as pneumonitis, cell fusion also inhibit virus cellular spread (Foa-Tomasi
bone marrow suppression, and encephalitis (Drobyski et et al., 1991a). Similarly, preincubation of infectious virus
al., 1993, 1994; Cone et al., 1993; Morris et al., 1989; with these antibodies neutralise virion infectivity and re-
Carrigan et al., 1991; Knox et al., 1995a,b). A possible sults in the absence of cytopathology. These MAbs are
association with multiple sclerosis has also been pre- specific for glycoprotein gH (Liu et al., 1993b). Therefore,
HHV-6 gH is a glycoprotein with fusogenic properties, in-
volved in both the initiation of infection and spread of infec-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: /44 171 637 4314. E-mail: ugompels@hgmp.mrc.ac.uk. tious virus from cell to cell. All subfamilies of herpesviruses
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examined to date have a gH homologue with similar prop- can be extended to HHV-6 gH and gL in that human sera
recognises the gH/gL complex better than gH expressederties (Gompels and Minson, 1986; McGeoch and Davison,
alone and shows no reaction to gL (Liu et al., 1993a).1986; Keller et al., 1987; Oba and Hutt-Fletcher, 1988; Cran-
However, given their similarity, especially to HCMV-en-age et al., 1988; Gompels et al., 1988a,b; Heineman et al.,
coded products, some of the properties of the complex1988; Pachl et al., 1989; Gompels et al., 1991, 1992). Sensi-
between gH and gL in mediating processing and trans-tive dot matrix analysis of related gH homologues indicates
port may also apply to HHV-6.that at the amino acid level conservation is most obvious
Previous data for the gH and gL homologues indicatesat the C-terminus whilst N-terminal amino acid sequences
there are separate domains for interaction with gL andare more divergent and only shared within subgroups
for mediating cell fusion. All gH homologues have proper-(Gompels et al., 1988b). HHV-6 gH shares most similarity
ties in mediating fusogenic cellular spread, and only thein both N and C terminal domains with gH from the betah-
C-terminal cysteine domain is conserved in all herpesvi-erpesvirus subfamily which includes HCMV (Gompels et
rus gH homologues, therefore this domain has been im-al., 1992).
plicated in cell fusion (Gompels et al., 1988b). ConsistentWe have previously demonstrated that in HHV-6-in-
with this observation is our previous study showing thatfected cells gH associates with a conserved virus en-
at least part of the HHV-6 gH domain involved in fusioncoded glycoprotein called gL (Liu et al., 1993a,b). This
is located in the external portion of gH in a 23 amino acidphysical association can be reproduced in vitro by coex-
region that includes a conserved N-linked glycosylationpression in rabbit reticulocyte lysates or by transient
motif, although long-range effects that involve the N-ter-coexpression in cultured cells. Heterooligomer complex
minus of gH cannot be formally excluded as this regionformation has been demonstrated for herpes simplex vi-
was defined by conformation-dependent antibodies (Liurus type 1 (HSV-1) (Gompels and Minson, 1989; Foa-
et al., 1993b). In contrast, analysis of antibody-resistantTomasi et al., 1991b; Hutchinson et al., 1992), HCMV
mutants in HSV-1 gH has shown that the nonconserved(Kaye et al., 1992) and EBV (Yaswen et al., 1993). Unlike
N-terminal domain may interact with gL. In this studygH, gL does not have significant sequence similarity
antibody recognition is dependent on gH interaction withacross herpesvirus subgroups and has been identified
another virus protein (subsequently shown to be gL) andas a ‘‘positional’’ homologue which encodes a small se-
maps to a conformational dependant epitope spanningcreted glycoprotein with similar properties in complex
the N-terminal 320 amino acids (Gompels et al., 1991).formation with gH (Kaye et al., 1992). However, like gH,
Thus, in the external domain there is evidence for at leastwithin a subgroup there is sequence similarity through-
two separate domains, one for gL interaction which isout the entire sequence based primarily around con-
necessary for conformation and the second for mediatingserved cysteines and this is observed between both gH
fusion or interaction with a cellular fusogen. The objectand gL homologues of HCMV and HHV-6.
of this work was first to investigate interactions betweenData from HSV-1 and HCMV studies indicate that gH
HHV-6 gH and gL to determine which domain governstogether with gL forms a complex which is an important
these intermolecular interactions within this virus andfunctional unit required for infection and cellular spread.
second, to investigate the nature of the betaherpesvirus-Expression of gH in the absence of other viral proteins
specific sequence conservation across both the N and C
results in an antigenic conformation distinct from those
terminal domains and whether this is sufficient to permit
observed in HSV-1-infected cells and wild type (wt) con-
functional substitution in terms of heterooligomer forma-
formation can be restored by the presence of specific tion. Finally, as there are conserved cysteines throughout
virus protein (Gompels and Minson, 1989; Foa-Tomasi the HHV-6 and HCMV gH and gL homologues our third
et al., 1991b; Gompels et al., 1991). Recently, it has been objective was to determine the role of disulphide bond
shown that normal processing can be achieved by coex- formation in complex formation.
pression with gL (Hutchinson et al., 1992). Likewise, in Our results show a HHV-6 gH domain required for
the absence of gL, gH is not transported to the plasma interaction between gH and gL that is common to other
membrane and is detected predominantly as perinuclear betaherpesviruses. We also demonstrate betaherpesvir-
staining (Gompels and Minson, 1989; Cranage et al., uses-specific substitution of gH or gL and heterologous
1988; Roberts et al., 1991; Hutchinson et al., 1992; Kaye gH/gL complex that is dependent on disulphide bond
et al., 1992; Spaete et al., 1993). Coexpression of gH formation. These results contribute significantly to the
with gL results in transport to the plasma membrane understanding the functions of gH and gL in HHV-6
(Gompels and Minson, 1989; Hutchinson et al., 1992; pathogenesis and suggest ways in which related viruses
Kaye et al., 1992). Inappropriate transport of gH through may interact in vivo.
intracellular membranes is reflected by aberrant post-
MATERIALS AND METHODStranslational modification (Gompels and Minson, 1989;
Cells, virus, and plasmidsRoberts et al., 1991) and presumably accounts for at least
some of the observed conformational differences. As yet Vero cells were grown in Dulbecco’s modified Eagle’s
(DME) medium supplemented with 10% fetal calf serumthere is only limited evidence that these observations
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(FCS) and 1% penicillin–streptomycin (ICN Flow). BHK (Kaye et al., 1992) into BglII/BamHI cut pIBM6 (Liu et al.,
1991).cells were maintained in Glasgow modified Eagle’s me-
dium supplemented with 10% newborn calf serum (NCS),
Transient transfection system and labeling of cells10% tryptose phosphate broth and antibiotics as de-
scribed above. Vaccinia virus (vTF7) was grown in BHK The gH and gL genes cloned between the T7 promoter
cells and titre determined by plaque assay on Vero cells. and terminator were expressed transiently in mammalian
Plasmids pH6H2 and pH6CH2, encoding the nucleotide cells as described by Fuerst et al. (1986). Plasmids were
sequence of HHV-6 strain U1102 gH and gL, respectively, introduced via liposome-mediated transfection using
and plasmids expressing mutant forms of HHV-6 gH conditions recommended by the manufacturer (Gibco
(pH6H4, pH6H5, and pH6H6) have been described else- BRL) into subconfluent monolayers of Vero cells already
where (Liu et al., 1993a,b). infected with 1 PFU/cell of recombinant vaccinia virus
vTF-3 expressing T7 RNA polymerase. Cell culture me-
Monoclonal antibodies dium was replaced 4 hr posttransfection with DME me-
dium minus methionine (Gibco BRL) with the growth sup-MAb LP14 (Minson et al., 1986), which recognises a
plements indicated above. Proteins were radiolabelednine-amino-acid linear epitope from HSV-1 gD (Liu et al.,
with 30 mCi [35S]methionine (1000 Ci/mmol; Amersham)1991), was a gift from Dr. A. C. Minson, Department of
for 13 hr at 377.Pathology, University of Cambridge, U.K. 12CA5 supplied
from BAbCO, U.S.A. is specific for a nine amino acid
Immunoprecipitation and gel electrophoresisepitope from influenzavirus haemagglutinin type 1 (Wil-
son et al., 1984). Labeled cells were washed three times in ice-cold
PBS, harvested in 0.5 ml RIPA buffer (50 mM Tris–HCl,
Site-directed mutagenesis pH 7.5, 150 mM NaCl, 1% sodium deoxycholate, 0.1%
SDS, 1% Nonidet P-40) and cellular debris pelleted by
Oligonucleotide directed in vitro mutagenesis of sin-
centrifugation at 13,000 g for 20 min. Cell lysates were
gle-stranded DNA was carried out using the Kunkel
precleared by addition of 25 ml of a 1:1 mix of RIPA
(1985) method and components supplied by Bio-Rad. Pu-
buffer:protein A Sepharose (Sigma) for 1 hr at 47 followed
tative mutants were screened, and the entire gene se-
by centrifugation. Equivalent TCA precipitable counts
quence was determined by nucleotide sequencing
were diluted to 0.5 ml with RIPA buffer, and 1 ml of the
(Sanger et al., 1977) using a commercially available T7
appropriate MAb was added and rotated at 47 for 18 hr.
promoter primer (Promega) and internal gH primers
Immune complexes were precipitated using protein A
(Gompels et al., 1993).
Sepharose, washed three to five times using 1 ml of lysis
buffer, and bound proteins disassociated in 15 ml loading
Plasmid constructs
buffer. Samples were subjected to electrophoresis in sin-
gle percentage (12%), or 4–12% gradient precast mini-Plasmids pH6H7, pH6H8, pH6H9, pH6H10 (based on
polyacrylamide gels (Novex) under denaturing, reducingplasmid pH6H4), and pH6CH4 were constructed by site-
conditions unless indicated otherwise. Gels were fixedspecific mutagenesis (Fig. 1). Deletion mutants pH6H7,
and treated with Amplify (Amersham) according to thepH6H9, and pH6H10, progressively removing portions of
manufacturers instructions prior to exposure to Hyperfilmthe external domain of gH, were constructed by insertion
(Amersham) for fluorography.in-frame of a stop codon. Oligonucleotide 1, 5* CCTACC-
GATTAACGCATGCAG 3*, which contained a single base
RESULTSchange (bold type) was used to delete from D 433 giving
plasmid pH6H7. Oligonucleotide 2, 5* GACAGATGCAAT- The external portion of gH contains a region required
AGGACAACGTTTCCT 3* was used to construct plasmid for gL association
pH6H9 which is deleted from Q 145. Oligonucleotide 3,
5* TTGACAGACGATTAACTATTGATAGTC 3*, was uti- A schematic representation of HHV-6 gH is shown in
Fig. 1. (pH6H2). The amino acid sequence of gH haslised to delete from D 230 generating plasmid pH6H10.
Oligonucleotide 4, 5* GTTAGCCAAATTTGAGATGTC 3*, features typical of N-linked glycosylation (Gavel and von
Heijne, 1990) which may occur at 14 possible sites andwas used to make pH6H8, which is deleted for four co-
dons. Plasmid pH6CH4 was constructed by introduction includes motifs conserved in HHV-6 (N3-N10) and in all
herpesvirus subfamilies (N14). There are a total of 14of the DNA sequence encoding the epitope for MAb
12CA5 in-frame in the HHV-6 gL gene after codon 29 cysteines residues in gH, 12 of which are found in other
representative herpesviruses, suggesting conservationusing oligonucleotide 5 (the encoded epitope is under-
lined): 5* CTTTCTATTTTTACCCATACGATGTTCCAGAT- of a functional role. These are abbreviated as C1 for
betaherpesviruses only, C2 for beta- and gammaherpes-TACGCTGAAAAACTTGAC 3*. HCMV AD169 UL75 (gH)
and UL115 (gL) were subcloned from the vector pRK19 viruses, and C3 for alpha-, beta- and gammaherpesvi-
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FIG. 1. Schematic view of HHV-6 gH (pH6H2) illustrating the epitope tag position in pH6H4. The putative signal peptide (SP) and transmembrane
(TM), external, and cytoplasmic domains are illustrated. Possible sites of N-linked glycosylation are indicated (N1-14). Conserved cysteines are
marked C1 (betaherpesvirus specific), C2 (beta and gammaherpesvirus specific), and C3 (alpha, beta, and gammaherpesvirus specific). Mutant
forms of gH (pH6H5-10) are pictured underneath. The numbered mutant residues refer to the amino acids in gH excluding the epitope tag. Boxed
areas indicate regions conserved amongst gH homolgues determined by dot matrix analysis, amino acid sequence comparisons (Gompels et al.,
1988b, 1992), and multiple alignments of HHV-6 gH with all gH homologues identified to date.
ruses (Fig. 1). We have previously defined antibody re- amino acids from the N-terminus of gH which includes a
pair of cysteine residues conserved in betaherpesvirusesagents specific for HHV-6 gH, including human sera and
MAbs (Liu et al., 1993a,b). In addition, we have inserted (C1). Recombinant pH6H10 is deleted for a region that
encompasses paired cysteine residues conservedat the beginning of the protein, a linear epitope in gH
(pH6H4) which is recognised by LP14 (Liu et al., 1993a). amongst beta and gamma herpesviruses (C2 and C3).
The ability of the mutant forms of HHV-6 gH to interactThis has provided a useful tool for studying protein –
protein interactions without relying on endogenous epi- with HHV-6 gL was examined by transient coexpression
in Vero cells. The total amount of radiolabeled proteinstopes which may be the target of antibodies that interfere
with binding. The truncated forms of gH employed in this immunoprecipitated was approximately equal (see Mate-
rials and Methods) (Fig. 2, lanes 2–10). As expected,study are also illustrated in Fig. 1. Mutant pH6H5 and
pH6H6 have been described previously (Liu et al., 1993b), epitope-tagged gH and gL were coimmunoprecipitated
by MAb LP14 when expressed in combination (Fig. 2,the former lacking the C-terminal sequences which form
the putative cytoplasmic anchor, transmembrane do- lane 13), whereas only tagged gH and not gL was immu-
noprecipitated when both proteins were expressed indi-main, and the N14 conserved glycosylation site within
the external domain. The latter, pH6H6, is deleted for a vidually (Fig. 2, lanes 11 and 12, respectively). The gH
recombinants were competent for interaction with gL, assimilar region but retains the entire external domain.
pH6H7 encodes two-thirds of the gH ectodomain and demonstrated by coimmunoprecipitation of gL (Fig. 2,
lanes 14–17 and 19), with the exception of mutant pH6H9specifically does not include six cysteine residues con-
served amongst all herpesvirus subfamilies (C3). pH6H8 which failed to immunoprecipitate detectable amounts
of gL (Fig. 2, lane 18). This lack of binding was observedhas an in-frame 12-bp deletion that removes the con-
served N14 glycosylation site NGSV. pH6H9 retains 145 even though equal counts had been loaded per lane,
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FIG. 2. Total [35S]methionine-labeled protein extracts from transfected Vero cells (lanes 2 to 10) were immunoprecipitated with LP14 (lanes 11 to
19). Lanes 2 and 11, pH6H4 (LP14 epitope tagged gH); and lanes 3 and 12, pH6CH2 (wt gL). Lanes 3 to 10 and 12 to 19 were all transfected with
pH6CH2 and in addition pH6H4 (lanes 4 and 13), pH6H5 (lanes 5 and 14), pH6H6 (lanes 6 and 15), pH6H7 (lanes 7 and 16), pH6H8 (lanes 8
and 17), pH6H9 (lanes 9 and 18), and pH6H10 (lanes 10 and 19), respectively. 14C-labeled molecular weight markers are indicated in kilodaltons
(lane 1).
and was highlighted by the observation that while similar ity of the exogenous 12CA5 epitope for gL. 12CA5 coim-
munoprecipitated wt gH and epitope-tagged gH (Fig. 3,intensities were observed for H7 and H9 gH mutant
bands, only H7 clearly coprecipitated gL and H9 did not lanes 23 and 25) with tagged gL. In the reciprocal experi-
ment, LP14 immunoprecipitated tagged gH (Fig. 3, lane(Fig. 2, lanes 16 and 18). Overexposure from 3 (Fig. 2) to
30 days gave the same result. In the overexposed film 11) and coimmunoprecipitates wt or tagged gL with
tagged gH (Fig. 3, lanes 16 and 17). Therefore, addition ofH9 shown in lane 18 is darker than any other band shown
in Fig. 2, but gL is absent. Therefore, the HHV-6 gH cyto- the 12CA5 antibody recognition site to gL did not interfere
discernibly with gH association and confirmed directlyplasmic, transmembrane sequences and part of the ex-
ternal domain which incorporates paired cysteine resi- the interaction and identity of HHV-6 gL with gH as ob-
served indirectly previously by coimmunoprecipitationdues (C3) conserved in all herpesviruses as well as those
conserved only in beta and gammaherpesviruses (C2) with gH using gH antibodies (Liu et al., 1993a,b).
are not required for complex assembly. These results
define the region necessary for association with gL to HCMV gH interacts with HHV-6 gL and HCMV gL can
the N-terminal 230 amino acids of gH which includes substitute for HHV-6 gL to form a heterologous
paired cysteine residues (C1) only conserved amongst complex with HHV-6 gH
betaherpesviruses (Fig. 1).
As the domain defined in HHV-6 gH for interaction with
gL contains sequences conserved only in the betaher-Epitope-tagged gL interacts with gH
pesviruses, the possibility of interactions between glyco-
proteins from different betaherpesviruses was examined.The coding region for a nine-amino-acid linear epitope
from influenza virus haemagglutinin type 1 was inserted To this end, epitope-tagged HHV-6 gL was coexpressed
with HCMV gH and complex formation assayed by immu-in-frame at the N-terminus of HHV-6 gL upstream of the
putative signal sequence cleavage site. Thus, MAb noprecipitation with the MAb specific for the epitope tag,
12CA5. This MAb coimmunoprecipitated both gL and12CA5, specific for this epitope, can be used in immuno-
precipitations to examine gH/gL interactions through gL. HCMV gH (Fig. 4, lane 7), whereas HCMV gH was not
immunoprecipitated when expressed by itself (Fig. 4,In Fig. 3 wt gH and gL and epitope-tagged gH or gL are
expressed individually or in combination. The cell lysate lane 5). This shows that HCMV gH forms a heterologous
complex with HHV-6 gL. To further examine interactionsfrom each transfection was divided into aliquots of equiv-
alent counts (Fig. 3, lanes 2–9) and immunoprecipitated between betaherpesviruses, HHV-6-tagged gH (wt and
deletions) and HCMV gL were expressed individually orwith LP14 or 12CA5 (lanes 10–17 and 18–25, respec-
tively). 12CA5 immunoprecipitated only tagged gL (Fig. were coexpressed followed by immunoprecipitation with
the gH tagging MAb, LP14. Figure 5 shows that HHV-63, lane 21), and not other glycoproteins without the epi-
tope tag (Fig. 3, lanes 18– 20), demonstrating the specific- gH and HCMV gL form a heterologous complex (lane 13)
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FIG. 3. Total [35S]methionine-labeled protein extracts from transfected Vero cells (lanes 2 to 9) were immunoprecipitated with LP14 (lanes 10 to
17) or 12CA5 (lanes 18 to 25). Lanes 2, 10, and 18, pH6H2 (wt gH); lanes 3, 11, and 19, pH6H4 (LP14 epitope-tagged gH); lanes 4, 12, and 20,
pH6CH2 (wt gL); lanes 5, 13, and 21, pH6CH4 (12CA5 epitope-tagged gL); lanes 6, 14, and 22, pH6H2 and pH6CH2; lanes 7, 15, and 23, pH6H2
and pH6CH4; lanes 8, 16, and 24, pH6H4 and pH6CH2; lanes 9, 17, and 25, pH6H4 and pH6CH4. 14C-labeled molecular weight markers are indicated
in kilodaltons (lane 1).
in transfected cells. Limited evidence derived from in minal one-third of HHV-6 gH described for the homolo-
gous system. Since HCMV gL interacts with mutantvitro transcription/translation and transient expression
studies suggest that the association between HHV-6 gH pH6H9 (Fig. 5, lane 18), this implies that the incapacity
of this HHV-6 gH deletion to bind HHV-6 gL is not aand HCMV gL is more stable than that between HHV-6
gH and gL (Liu et al., 1993a and unpublished results). consequence of localisation to an inappropriate cellular
compartment. Also, this indicates that whilst there areHCMV gL was coexpressed with the panel of HHV-6
gH mutants and immunoprecipitated with LP14. HCMV common interaction properties, there are differences be-
tween homologous and heterologous complex formation.gL was able to interact with all the gH recombinants
including pH6H9 which was unable to complex with These features may reflect differences in complex stabil-
ity and/or a dependence on homodimer formation forHHV-6 gL (Fig. 5, lanes 11–19). Therefore, the domain
involved in heterologous interaction overlaps the N-ter- quarternary complex assembly by HHV-6 glycoproteins.
Disulphide bond formation contributes to gH/gL
complex formation
To investigate the role of disulphide bond formation
and complex stability the HHV-6 gH and gL were ana-
lysed under nonreducing conditions. HHV-6 gH and gL
share amino acid homology with their HCMV counter-
parts. Under nonreducing conditions HCMV gH ex-
pressed together with gL forms a multimeric complex
that involves disulphide linkages, while HCMV gH ex-
pressed individually remains monomeric (Kaye et al.,
1992). Given the similarities to HCMV, our current work-
ing model is that conserved cysteine residues may play a
role in HHV-6 gH/gL complex formation. Our observation
above, that the HHV-6 gH domain required for gL interac-
tion includes betaherpesvirus-specific cysteines resi-
dues is in agreement with this hypothesis. Therefore,
epitope-tagged gH or gL were expressed individually or
in combination, immunoprecipitated with the relevant
FIG. 4. Total [35S]methionine-labeled protein extracts from tagging MAbs, LP14 or 12CA5, as indicated and electro-
transfected Vero cells (lanes 2 to 4) were immunoprecipitated with phoresed on a denaturing nonreducing 4–12% gradient
12CA5 (lanes 5 to 7). Lanes 2 and 5, pCMVgH (HCMV gH); lanes 3
SDS polyacrylamide gel. Under these conditions a minorand 6, pH6CH4 (12CA5 epitope-tagged HHV-6 gL); lanes 4 and 7,
species of gH that corresponded to the gH monomerpCMVgH and pH6CH4. 14C-labeled molecular weight markers are indi-
cated in kilodaltons (lane 1). routinely detected in the presence of reducing agents
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FIG. 5. Total [35S]methionine-labeled protein extracts from transfected Vero cells (lanes 2 to 10) were immunoprecipitated with LP14 (lanes 11 to
19). Lanes 2 and 11, pH6H4 (LP14 epitope-tagged HHV-6 gH); lanes 3 and 12, pUL115 (HCMV gL); lanes 4 and 13, pH6H4 and pUL115; lanes 5
and 14, pH6H5 and pUL115; lanes 6 and 15; pH6H6 and pUL115; lanes 7 and 16, pH6H7 and pUL115; lanes 8 and 17, pH6H8 and pUL115; lanes
9 and 18, pH6H9 and pUL115; lanes 10 and 19, pH6H10 and pUL115. 14C-labeled molecular-weight markers are indicated in kilodaltons (lane 1).
was observed (Fig. 6, lane 2). However, most gH was lanes 3 and 4). Thus, homodimer formation mediated by
disulphide bonds is observed for either HHV-6 gH or gL.resolved as a high-molecular-weight complex (gH*) that
may correspond to a homodimer (Fig. 6, lane 2). Likewise, Coexpression of epitope-tagged gH and gL and immuno-
precipitation with LP14 resulted in the absence of gL andmost gL was discernable as a homodimer (gL*) and there
was a small proportion of monomeric gL detected (Fig. gL* products and the appearance of a novel species that
migrated slower than gH* alone (Fig. 6, lane 6), implying6, lane 5). MAbs directed against gH or gL did not non-
specifically immunoprecipitate other proteins (Fig. 6, that the gH/gL multimer is complexed via disulphide link-
ages and is probably a tetramer composed of gH and
gL homodimers. In combination with the data from Kaye
et al. (1992) these results show that both HHV-6 and
HCMV can form multimeric gH/gL complexes mediated
by disulphide bonds, but their assembly may differ start-
ing with homodimers for HHV-6 and monomers for
HCMV. Therefore, assembly of gH/gL quarternary struc-
tures has distinct prerequisites in different betaherpesvi-
ruses.
DISCUSSION
In this paper we describe a HHV-6 gH region required
for interaction with another glycoprotein, gL. The domain
consists of 230 amino acids from the N-terminal extracel-
lular portion of gH and contains several amino acids
that are conserved in betaherpesviruses including paired
cysteines (C1; Figs. 1 and 2). The nature of the betaher-
pesvirus specificity to this conserved domain suggestsFIG. 6. Immunoprecipitations with LP14 (lanes 2, 4, and 6) and 12CA5
that our observations are likely to apply to other betaher-(lanes 3 and 5) of protein extracts from Vero cells transfected with
pH6H4 (LP14 epitope-tagged gH) in lanes 2 and 3, pH6CH4 (12CA5 pesviruses such as murine cytomegalovirus and human
epitope-tagged gL) in lanes 4 and 5, or pH6H4 and pH6CH4 (lane 6). herpesvirus-7 (HHV-7). Also, we present the first demon-
Products were run on a 4–12% gradient SDS polyacrylamide gel under stration of functional substitution of proteins between
denaturing, nonreducing conditions. Arrows indicate the positions of
different herpesviruses of the betaherpesvirus subgroupgH and gL monomers, gH and gL homodimers (denoted by *), and
(Figs. 4 and 5).the position of the high-molecular-weight gH/gL heterooligomer. 14C-
labeled molecular-weight markers are indicated in kilodaltons (lane 1). The gL interaction domain is formed by the N-terminal
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third of gH which is variant between subgroups and con- disturb cellular functions. Thus, a T7-based plasmid vec-
tor was used without an internal ribosome binding siteserved within subgroups. Similarly, gL itself is only con-
served within subgroups. Within the alphaherpesviruses (which allows for efficient translation of the abundant
uncapped T7 produced transcripts, resulting in abnor-there is also evidence for interaction of HSV-1 gL with
the N-terminal third of HSV-1 gH. Here a conformational mally high levels of overexpressed protein) combined
with reduced multiplicities of infection with the superin-epitope dependent on interaction with gL has been de-
fined by sequence analyses of antibody-resistant mu- fecting T7 recombinant vaccinia virus. Subsequently, gH
or gL expression was not detected above the backgroundtants (Gompels et al., 1991). Thus, the N-terminal third
of gH homologues may be a general rule for interaction total protein profile. Second, heterologous complex for-
mation was not detected between unrelated viral glyco-with gL and may explain the diversity of sequence ob-
served here and in gL. Although there may be similarity proteins and HHV-6 gH or gL (data not shown). Finally,
the interaction of HHV-6 gL with HHV-6 gH could bein domains of gH homologues interacting with gL, there
also appear to be differences in strategies for complex eliminated by deletion of gH from amino acid 145.
We mapped the domain for heterologous interactionassembly. The mechanism for HSV-1 gH and gL complex
formation is not known but does not appear to involve to a region similar to the homologous system. It will be
important to assess if heterologous binding equates todisulphide bonds (Hutchinson et al., 1992). In contrast,
disulphide linkages are an important feature of gH/gL correct processing, cellular localisation, and cell fusion.
We show evidence that the N-terminal domain is involvedcomplex formation in betaherpesviruses examined to
date. Under nonreducing conditions HCMV gH and gL in interaction with gL and our former studies indicate that
the C-terminal domain appears to function in cell fusionform a high-molecular-weight complex that is composed
of gH and gL monomers (Kaye et al., 1992). Similarly, (Liu et al., 1993b). This contrasts with the observation in
the alphaherpesviruses that amino acids in the HSV-1 gHinteraction between HHV-6 gH and gL results in the for-
mation of a large complex with intermolecular disulphide cytoplasmic tail are important for syncytia formation in a
trans complementation assay (Wilson et al., 1994). Thebridges (Fig. 6). However, there also appear to be distinc-
tions in HHV-6 assembly although they can functionally reason for this discrepancy is not clear but may be a
consequence of mutant forms of HSV-1 gH having alteredsubstitute in complex formation. The HHV-6 complex ap-
pears to be formed from gH and gL disulphide-linked flexiblity in the plasma membrane, or requirements for
rescue of a particular HSV-1 syn mutant strain. HSV-1 ishomodimers (Fig. 6) whereas this is clearly not observed
in studies of HCMV gH (Kaye et al., 1992). This extra only fusogenic in these in vitro mutants which are derived
from mutations in a number of other glycoproteins,requirement in HHV-6 for homodimer formation before
gH/gL complex formation may explain the failure of gH whereas both HCMV and HHV-6 wild-type viruses are
fusogenic. In this respect, it is notable that HHV-6 andmutant pH6H9, 145 residues, to interact with HHV-6 gL
whilst retaining the capacity for stable complex formation HCMV both have small cytoplasmic domains of 6 amino
acids compared to 14 found in HSV-1 gH. Thus, there maywith HCMV gL. This is also consistent with our results
from in vitro transcription–translation reactions where a be differences in anchorage or membrane fluidity of the
glycoproteins from the different subgroups. However, thisstable complex is not formed between the homologous
HHV-6 gH and gL but is formed between the heterolo- is clearly not important for gH and gL complex formation
as truncated HHV-6 gH molecules containing no trans-gous HHV-6 gH with HCMV gL. In this regard, it is not
clear if mutant pH6H9 lacks homologous gL binding be- membrane or cytoplasmic domains interact with either
HHV-6 gL or HCMV gL (Figs. 2 and 5).cause it does not form conformationally correct dimers
or because it fails to form heteroligomers. Recent results There are precedents in other virus systems for glyco-
protein substitution. Herpesvirus glycoprotein gB homo-show that all the gH mutants can form homodimers, al-
though the ratio between amounts of monomers and di- logues share a relatively high level of amino acid se-
quence homology. Trans-complementation experimentsmers is now being assessed for contributions towards
conformational competence or stability. The ability of the using alphaherpesvirus mutants lacking gB have shown
that bovine herpesvirus-1 gB can substitute for pseudora-four conserved cysteine residues to potentiate homodi-
mer formation and oligomerization will be examined by biesvirus (PrV) gB (Kopp and Mettenleiter, 1992) and that
PrV gB can compensate for an HSV-1 gB defect (Metten-site-directed mutagenesis.
We have shown functional substitution of gH and gL leiter and Spear, 1994). Interestingly, HSV-1 gB was un-
able to complement a PrV gB deletion mutant (Metten-by related glycoproteins from the same herpesvirus fam-
ily. Both HCMV gH and gL were able to form a stable leiter and Spear, 1994). Although the sequence similarity
between the betaherpesvirus HCMV and HHV-6 gH andassociation with their HHV-6 counterparts. Several lines
of evidence suggest that these results are not due to gL is less than that for gB homologues, it is sufficient for
functional homology in the context of complex formationnonspecific interactions. First, our expression studies
were designed to overproduce glycoproteins in order to and probably represents conservation of tertiary struc-
ture.facilitate detection but not to the level where it would
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